Research presentation
Re-Architecting Healthcare Delivery with AI: From labour-driven care to AI-powered systems
Health Management Solutions have become healthcare's essential operating layer, capturing $5.6B in 2025 venture funding—with 83% flowing to AI ventures. Galen Growth’s 2026 Re-Architecting Healthcare Delivery with AI report — powered by HealthTech Alpha — tracks 1,746 ventures across the four functional layers of the modern health system, with full regional snapshots for the United States, Europe, and Asia Pacific. The definitive 2026 reference for investors, health systems, pharma, and digital health ventures.
About this report
- Operations & Workflow leads adoption: Healthcare operations is the primary entry point for AI, capturing the largest share of ventures and funding driven by measurable ROI and procurement readiness. Healthcare Operations & Workflow captures 49% of all Health Management Solutions ventures globally and 46% of health-system partnerships in the cluster.
- AI is now core infrastructure: AI-powered ventures captured $4.4B—representing 83% of all Health Management Solutions venture funding in 2025—supported by accelerating FDA clearances.
- Scaled platforms are pulling ahead: The market is rapidly consolidating; 25% of older ventures have exited, and M&A remains highly active as buyers seek enterprise-ready platforms. 21% of older ventures are inactive, M&A activity holds steady at 37–41 deals per year, and average deal size has tripled from $11.9M (Q1 2022) to $35.4M (Q1 2026).
- Regional strategies must diverge: North America dominates in scale, Europe differentiates through clinical intelligence, and Asia Pacific represents the fastest-growing greenfield opportunity. The United States hosts 41% of global ventures and recorded $4.5B of 2025 funding (1.8x YoY); Europe holds 23% with Clinical Decision Intelligence taking 47% of regional capital; Asia Pacific funding surged +87% YoY in 2025.
- Partnerships are fewer but deeper: Overall partnership volume declined as health systems shifted away from exploratory pilots in favour of enterprise-scale deployments with selected vendors. Partnership volume fell 25% from 846 in 2024 to 636 in 2025, while health-system partnerships specifically dropped from a 2024 peak of 247 to 165 — a clear signal of selective enterprise procurement.
Google Cloud, Microsoft, Oracle Cerner, Epic Systems, Menlo Ventures, General Catalyst, Bessemer Venture Partners, Flare Capital Partners, Andreessen Horowitz (a16z), F-Prime Capital, Chamber Cardio, House Rx, Qualified Health, Hippocratic AI, WellBeam, Aledade, Abridge, CMR Surgical, Airstrip Technologies, WHOOP, Harbinger Health, Universal Diagnostics, Midi Health, Zarminali Health.
- Investors: Concentrate your capital strategically by identifying proven, late-stage AI-native platforms in a consolidating, winner-takes-most market where 83% of funding now flows to AI ventures.
- Corporates (Health Systems & Pharma): Learn how to successfully scale AI from isolated pilots to enterprise-wide deployments that deliver measurable ROI, alleviate severe workforce shortages, and build critical data infrastructure.
- Ventures: Discover why you must prove enterprise-readiness—by demonstrating real-world evidence, regulatory credibility, and deep workflow integration—or risk being locked out of health system procurement and future capital.
The report is powered by HealthTech Alpha, The most trusted Digital Health actionable intelligence and insights platform for healthcare leaders. Leveraging an extensive database of over 16,000 ventures and cutting-edge analytics, HealthTech Alpha transforms fragmented information from over 30,000 sources into structured, traceable intelligence that supports screening, benchmarking, diligence, and monitoring.
Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence that can be integrated directly into your LLM tools to navigate digital transformation complexities, equipping you to identify strategic opportunities, assess market dynamics, and stay ahead in this fast-evolving industry.
Featured Statistics
Venture capital deployed to Health Management Solutions in 2025, 18.8% of all global digital health funding.
Share of Health Management Solutions venture funding deployed to AI-powered ventures in 2025 (up from 61% in 2021).
Private, in-scope Health Management Solutions ventures identified globally across four functional categories.
Average deal size in Q1 2026, a 3× increase from $11.9M in Q1 2022.
Year-on-year funding growth in Asia Pacific Health Management Solutions in 2025, the fastest-growing region globally.
FDA regulatory approvals for Health Management Solutions ventures in 2025, up from 186 in 2024.
Health Management Solutions ventures raised $5.6 billion in 2025 across 213 disclosed rounds,
representing 18.8% of all global digital health funding, according to Galen Growth’s Digital Health 2026 report.
83% of all Health Management Solutions venture funding flowed to AI-powered ventures in 2025,
up from 61% in 2021. AI-enabled solutions captured $4.4 billion of the cluster’s $5.6 billion total.
Healthcare Operations & Workflow is the leading category, capturing 46% of total Health Management
Solutions funding in 2025 ($2.9 billion), followed by Clinical Data Infrastructure (29%) and Clinical
Decision Intelligence (18%).
Disease-agnostic platforms dominate the market, capturing 82% of Health Management Solutions funding.
Regional ecosystems reveal distinctly different priorities:
- North America: Dominates in scale, accounting for 41% of ventures and $4.5B in funding, with a heavy concentration of 49% in Healthcare Operations & Workflow.
- Europe: Differentiates through Clinical Decision Intelligence, which captured 47% of its funding. European ventures heavily rely on academic and clinical research organisation partnerships to meet strict validation requirements.
- Asia Pacific: Represents the fastest-growing greenfield opportunity with an 87% year-over-year funding surge. Because many APAC systems are digitising from the ground up, 34% of funding is directed at foundational Clinical Data Infrastructure and another 34% at Operations.
Copy short
Download and define the next step
Get the deck, then turn the Digital Health insight into a brief
Use the Get the presentation button when you are ready to open the access form. The Brief Builder stays in focus here so your team can describe the decision, output, and scope you need from Galen Growth before starting the conversation.
Answer three prompts to shape the follow-up work.
1. What decision are you trying to make?
2. What output would be most useful?
3. What scope should we prioritize?
Next step
Want the analysis behind the slides?
Tell us what decision you are trying to make. We can shape the data, company universe, and strategic interpretation around your market, portfolio, partnership, or investment question.
